Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bauss

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bone and Mineral|November 1, 1989
Antiestrogen and antiandrogen administration reduce bone mass in the ratS Feldmann, H W Minne, S Parvizi, et al.
The Journal of Clinical Investigation|May 15, 1997
Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2T Yoneda, A Sasaki, C Dunstan, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|October 13, 2010
Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgen-deficient aged ratsConcepcion De La Piedra, I Quiroga, M Montero, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 22, 1999
Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral propertiesM C Monier-Faugere, Z Geng, E P Paschalis, et al.
Blood|February 25, 1999
Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone diseaseS L Dallas, I R Garrett, B O Oyajobi, et al.
Journal of Gravitational Physiology : a Journal of the International Society for Gravitational Physiology|April 17, 2003
Disuse bone loss in hindquarter suspended rats: partial weightbearing, exercise and ibandronate treatment as countermeasuresL Schultheis, C B Ruff, S Rastogi, et al.
Bone|December 19, 2006
Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigsC C Glüer, K E Scholz-Ahrens, A Helfenstein, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bone and Mineral|November 1, 1989
Antiestrogen and antiandrogen administration reduce bone mass in the ratS Feldmann, H W Minne, S Parvizi, et al.
The Journal of Clinical Investigation|May 15, 1997
Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2T Yoneda, A Sasaki, C Dunstan, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|October 13, 2010
Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgen-deficient aged ratsConcepcion De La Piedra, I Quiroga, M Montero, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 22, 1999
Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral propertiesM C Monier-Faugere, Z Geng, E P Paschalis, et al.
Blood|February 25, 1999
Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone diseaseS L Dallas, I R Garrett, B O Oyajobi, et al.
Journal of Gravitational Physiology : a Journal of the International Society for Gravitational Physiology|April 17, 2003
Disuse bone loss in hindquarter suspended rats: partial weightbearing, exercise and ibandronate treatment as countermeasuresL Schultheis, C B Ruff, S Rastogi, et al.
Bone|December 19, 2006
Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigsC C Glüer, K E Scholz-Ahrens, A Helfenstein, et al.
Pageof 3